TETRALYSAL 300 MG CAP GEL DURA CT STR X 28
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1291600220074 -
GGREM
510101704118413 -
Código de barras
7897930761322
O que a fonte publica
- Detentor do registro
- GALDERMA BRASIL LTDA
- Princípios ativos
- LIMECICLINA
- Embalagem
- 300 MG CAP GEL DURA CT STR X 28
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- J1A - TETRACICLINAS E ASSOCIAÇÕES
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "TETRALYSAL 300 MG CAP GEL DURA CT STR X 28",
"holder": "GALDERMA BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7897930761322"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "510101704118413",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "00.317.372/0001-46",
"priceRegime": "Regulado",
"productName": "TETRALYSAL",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "300 MG CAP GEL DURA CT STR X 28",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "218.43",
"icms-12": "248.22",
"icms-17": "263.17",
"icms-18": "266.38",
"icms-19": "269.67",
"icms-20": "273.04",
"icms-21": "276.49",
"icms-22": "280.04",
"icms-23": "283.68",
"icms-17.5": "264.76",
"icms-19.5": "271.34",
"icms-20.5": "274.75",
"icms-22.5": "281.85",
"icms-12-alc": "245.24",
"icms-17-alc": "260.01",
"icms-18-alc": "263.18",
"icms-19-alc": "266.43",
"icms-20-alc": "269.76",
"icms-21-alc": "273.18",
"icms-22-alc": "276.68",
"icms-23-alc": "280.27",
"withoutTaxes": "215.81",
"icms-17.5-alc": "261.59",
"icms-19.5-alc": "268.09",
"icms-20.5-alc": "271.46",
"icms-22.5-alc": "278.46"
},
"pisCofinsList": "Positiva",
"substanceText": "LIMECICLINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "301.08",
"icms-12": "342.15",
"icms-17": "362.75",
"icms-18": "367.18",
"icms-19": "371.71",
"icms-20": "376.36",
"icms-21": "381.11",
"icms-22": "386.01",
"icms-23": "391.02",
"icms-17.5": "364.94",
"icms-19.5": "374.01",
"icms-20.5": "378.71",
"icms-22.5": "388.50",
"icms-12-alc": "339.03",
"icms-17-alc": "359.45",
"icms-18-alc": "363.83",
"icms-19-alc": "368.32",
"icms-20-alc": "372.93",
"icms-21-alc": "377.66",
"icms-22-alc": "382.49",
"icms-23-alc": "387.46",
"withoutTaxes": "298.34",
"icms-17.5-alc": "361.63",
"icms-19.5-alc": "370.62",
"icms-20.5-alc": "375.28",
"icms-22.5-alc": "384.95"
},
"invalidBarcodes": [],
"activeSubstances": [
"LIMECICLINA"
],
"therapeuticClass": "J1A - TETRACICLINAS E ASSOCIAÇÕES",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1291600220074",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "J1A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:510101704118413"